Israeli crowdfunding platform OurCrowd launches $50m digital health fund

Crowdfunding platform OurCrowd has unveiled a $50 million fund specifically targeting early-stage digital health companies.

The fund, called “OurCrowd Qure”, will focus on seed and series A digital health startup rounds and will be in collaboration with Johns Hopkins University which will provide validation of value and ongoing feedback for each startup.

“Digital health is one of the fastest growing sectors in terms of funding and M&A activity,” said OurCrowd CEO Jon Medved. “Exclusively focusing in digital health is important given the complexity of healthcare delivery and markets.”

Based in Israel, the fund will be managed by Allen Kamer, founder of population health and analytics company Humedica and former executive at Biogen, and Dr Yossi Bahagon, founder and former CEO of Israeli digital medicine startup Luminox Health.

“Digital health is starting to transform our lives. It is fundamentally about making medicine more personalised and comprehensive, empowering both patients and their medical teams,” said Bahagon. “The fund will focus on solutions that have a massive social and personal impact, while also offering highly attractive return potential over an appealing timeline.”

The fund is OurCrowd’s first digital health-focused crowdfunding venture, having already invested $300 million in tech startups since its founding in 2013.

Its portfolio of over 100 technology companies include MedAware, a big data startup aimed at eliminating prescription errors; Global Kinetics Corporation, developer of a Parkinson’s wearable capable of tracking symptoms; and ReWalk, creator of robotic assistance technology helping paraplegics walk again.  

Around 15 deals will be funded through OurCrowd Qure, ranging from around $250,000 in seed funding to around $3 million in series A investments.

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.